These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8422270)
21. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126 [TBL] [Abstract][Full Text] [Related]
22. Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline. Amieva H; Mokri H; Le Goff M; Meillon C; Jacqmin-Gadda H; Foubert-Samier A; Orgogozo JM; Stern Y; Dartigues JF Brain; 2014 Apr; 137(Pt 4):1167-75. PubMed ID: 24578544 [TBL] [Abstract][Full Text] [Related]
23. Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study. Wang PN; Yang CL; Lin KN; Chen WT; Chwang LC; Liu HC J Neurol; 2004 Mar; 251(3):314-20. PubMed ID: 15015012 [TBL] [Abstract][Full Text] [Related]
24. Characteristics of Alzheimer's disease patients with a rapid weight loss during a six-year follow-up. Guérin O; Andrieu S; Schneider SM; Cortes F; Cantet C; Gillette-Guyonnet S; Vellas B Clin Nutr; 2009 Apr; 28(2):141-6. PubMed ID: 19232792 [TBL] [Abstract][Full Text] [Related]
25. Behavioral syndromes in Alzheimer's disease. Devanand DP; Brockington CD; Moody BJ; Brown RP; Mayeux R; Endicott J; Sackeim HA Int Psychogeriatr; 1992; 4 Suppl 2():161-84. PubMed ID: 1288661 [TBL] [Abstract][Full Text] [Related]
26. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study. Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM; Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340 [TBL] [Abstract][Full Text] [Related]
27. Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment. Vellas B; Lauque S; Gillette-Guyonnet S; Andrieu S; Cortes F; Nourhashémi F; Cantet C; Ousset PJ; Grandjean H; J Nutr Health Aging; 2005; 9(2):75-80. PubMed ID: 15791349 [TBL] [Abstract][Full Text] [Related]
28. Weight loss as a predictor of dementia and Alzheimer's disease? Nourhashémi F; Vellas B Expert Rev Neurother; 2008 May; 8(5):691-3. PubMed ID: 18457525 [No Abstract] [Full Text] [Related]
29. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990 [TBL] [Abstract][Full Text] [Related]
30. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105 [TBL] [Abstract][Full Text] [Related]
31. Negative symptoms in Alzheimer's disease. Reichman WE; Coyne AC; Amirneni S; Molino B; Egan S Am J Psychiatry; 1996 Mar; 153(3):424-6. PubMed ID: 8610835 [TBL] [Abstract][Full Text] [Related]
32. A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer's disease subjects. White HK; McConnell ES; Bales CW; Kuchibhatla M J Am Med Dir Assoc; 2004; 5(2):89-97. PubMed ID: 14984619 [TBL] [Abstract][Full Text] [Related]
33. IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. Gillette Guyonnet S; Abellan Van Kan G; Alix E; Andrieu S; Belmin J; Berrut G; Bonnefoy M; Brocker P; Constans T; Ferry M; Ghisolfi-Marque A; Girard L; Gonthier R; Guerin O; Hervy MP; Jouanny P; Laurain MC; Lechowski L; Nourhashemi F; Raynaud-Simon A; Ritz P; Roche J; Rolland Y; Salva T; Vellas B; J Nutr Health Aging; 2007; 11(1):38-48. PubMed ID: 17315079 [TBL] [Abstract][Full Text] [Related]
35. Variables which distinguish patients fulfilling clinical criteria for dementia with Lewy bodies from those with Alzheimer's disease. Graham C; Ballard C; Saad K Int J Geriatr Psychiatry; 1997 Mar; 12(3):314-8. PubMed ID: 9152714 [TBL] [Abstract][Full Text] [Related]
36. Practical guidelines for the diagnosis and management of weight loss in Alzheimer's disease: a consensus from appropriateness ratings of a large expert panel. Belmin J; J Nutr Health Aging; 2007; 11(1):33-7. PubMed ID: 17315078 [TBL] [Abstract][Full Text] [Related]
37. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias. Allan LM; Ballard CG; Burn DJ; Kenny RA J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166 [TBL] [Abstract][Full Text] [Related]
38. A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Sultzer DL; Levin HS; Mahler ME; High WM; Cummings JL Am J Psychiatry; 1993 Dec; 150(12):1806-12. PubMed ID: 8238634 [TBL] [Abstract][Full Text] [Related]
39. Weight loss in adults with Down syndrome and with dementia in Alzheimer's disease. Prasher VP; Metseagharun T; Haque S Res Dev Disabil; 2004; 25(1):1-7. PubMed ID: 14733972 [TBL] [Abstract][Full Text] [Related]
40. Energy expenditure in Alzheimer's disease. Poehlman ET; Dvorak RV J Nutr Health Aging; 1998; 2(2):115-8. PubMed ID: 10993580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]